
Please try another search
Shenzhen Kangtai Biological Products Co., Ltd. researches and develops, produces, and sells various types of human vaccines in China. Its marketed vaccines include SARS-COV-2 vaccines, HIB conjugate vaccines, 13-valent pneumococcal conjugate vaccines, recombinant hepatitis B vaccines, 23-valent pneumococcal polysaccharide vaccines, diphtheria tetanus acellular pertussis and haemophilus influenzae type b combined vaccines, cell-free whitebait b-type haemophilus influenzae combined vaccines, and measles and rubella combined vaccines. The company’s research and development vaccines comprise rabies vaccine for human use, inactivated poliomyelitis vaccine, and live attenuated varicella vaccine. Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992 and is headquartered in Shenzhen, China.
Name | Age | Since | Title |
---|---|---|---|
Feidong Wen | 48 | 2021 | Vice Chairman |
Weimin Du | 61 | 2008 | Chairman of the Board |
Xiangming Li | 68 | 2025 | Independent Director |
Jiankai Liu | 55 | 2008 | VP & Non-Independent Director |
Feidong Wen | 51 | 2021 | Chairman of the Supervisory Board |
Xiang Miao | 52 | 2021 | President & Non-Independent Director |
Jiaoyu Li | 67 | 2021 | Independent Director |
Keping Hu | 65 | 2021 | Independent Director |
Anlong Xu | 62 | 2025 | Vice Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review